companydata.dkcompanydata.dk

MEJLGAARD INVEST ApS: Financial statements 2022

CVR: 10042933

Source: annual report 2022, Danish Business Authority

01/05/2021 – 30/04/2022

MEJLGAARD INVEST ApS (CVR 10042933) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -48,031 and a net result of DKK -493,634 compared with DKK 3,708,378 the year before. Equity in the 2022 report amounted to DKK 16,282,859. The solvency ratio was 99.8%. The company had 1 employee in the financial year.

Gross Profit
DKK -48,031
Profit/Loss
DKK -493,634
Equity
DKK 16,282,859
Total Assets
DKK 16,311,859
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--48K-494K16.3M1
2021--46K3.7M16.9M1
2020--40K1.2M13.3M1
2019--48K1.7M12.2M1
2018--42K391K10.6M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on MEJLGAARD INVEST ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Auditor steps down at MEJLGAARD INVEST ApSJun 10, 2022

As of June 10, 2022, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has stepped down as auditor of MEJLGAARD INVEST ApS.

About MEJLGAARD INVEST ApS

MEJLGAARD INVEST ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 1985. The company has been dissolved on 3 September 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company was previously named S.M.J. PHARMA AF 1/10 85 ApS. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -35,584 and a net result of DKK 99,498 compared with DKK -493,634 the year before. Equity in the 2023 report amounted to DKK 16,267,957.

Source: annual report 2023, Danish Business Authority